Cholangiocarcinoma of the Gallbladder Completed Phase 2 Trials for Leucovorin (DB00650)

IndicationStatusPhase
DBCOND0029558 (Cholangiocarcinoma of the Gallbladder)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01229111Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary CancersTreatment